Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

OBJECTIVES:

I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Center for Research Resources (NCRR)
• Collaborator: University of Vermont
• Treatments: Aminosalicylic Acid

Criteria

PROTOCOL ENTRY CRITERIA:

• Mildly to moderately severe ulcerative colitis

• Patient age: 18 to 80